Within its last year performance, CSII fell by -0.71%, with highs and lows ranging from $23.47 to $12.26, whereas the simple moving average jumped by 34.36% in the last 200 days. On December 21, 2022, Barclays started tracking Cardiovascular Systems Inc. (NASDAQ: CSII) recommending Equal Weight. A report published by Lake Street on December 14, […]
NEW YORK, Feb. 13, 2023 /PRNewswire/ -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national securities firm rated Top 50 in the 2018-2021 ISS Securities Class Action Services Report and headquartered…
Cardiovascular Systems is selling out to Abbott for $20/share in cash. Read more to see what this means for CSII shareholders.
Cardiovascular Systems Inc. (NASDAQ:CSII) shares, on Friday, February 10, remained unchanged to the previous day’s close as strong demand from buyers drove the stock to $19.75. Actively observing the price movement in the recent trading, the stock is buoying the session at $19.75, falling within a range of $19.69 and $19.85. The value of beta … Cardiovascular Systems Inc. (NASDAQ: CSII): A Great Stock To Watch Read More »
Gainers Hempacco Co., Inc. (NASDAQ: HPCO ) rose 296% to $2.99 after declining 6% on Wednesday. Cardiovascular Systems, Inc. (NASDAQ: CSII ) shares jumped 48.6% to $19.78 following Q2 results. Abbott Laboratories agreed to acquire Cardiovascular Systems for $20 per share for an equity value of approximately $890 million. Wearable Devices Ltd. (NASDAQ: WLDS ) shares jumped 48.5% to $0.9273 after the company received approval from the Israel Innovation Authority for a $900,000 grant. SelectQuote, Inc. (NYSE: SLQT ) surged 40% to $2.1150. SelectQuote recently reported better-than-expected Q2 EPS and sales results and raised the lower end of its FY23 sales guidance above estimates. Blue Bird Corporation (NASDAQ: BLBD ) jumped 37.7% to $19.00 following upbeat quarterly sales. AppLovin Corporation (NASDAQ: APP ) shares surged 29.8% to $16.46 after the company issued strong Q1 guidance. Doma Holdings Inc. (NYSE: DOMA ) gained 24% to $0.6211. Doma Holdings is expected to report Q4 financial results after the market close on Tuesday, Feb. 28, 2023.
Cardiovascular Systems Inc. (CSII)’s stock is trading at $19.76 at the moment marking a rise of 48.50% from the last session close. As of this writing, shares are priced at -15.79% less than their 52-week high of $23.47, and 61.28% over their 52-week low of $12.26. Based on the past 30-day period, the stock price […]
The medtech company has agreed to a buyout offer from Abbott Laboratories.
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Current Stocks Alert: Cardiovascular Systems, Inc. (NASDAQ:CSII 48.38%), AT&T Inc. (NYSE:T 0.05%) appeared first on Stocks Equity .
U.S. stocks traded higher, with the Dow Jones gaining around 150 points on Thursday. Here are some big stocks recording losses in today’s session. Cardiovascular Systems, Inc. (NASDAQ: CSII ) shares climbed 48.6% to $19.78 following Q2 results. Abbott Laboratories agreed to acquire Cardiovascular Systems for $20 per share for an equity value of approximately $890 million. Blue Bird Corporation (NASDAQ: BLBD ) gained 37.7% to $19.00 following upbeat quarterly sales. AppLovin Corporation (NASDAQ: APP ) shares rose 29.8% to $16.46 after the company issued strong Q1 guidance. 23andMe Holding Co. (NASDAQ: ME ) jumped 17.5% to $2.96 following strong quarterly sales. Sonos, Inc. (NASDAQ: SONO ) gained 16.4% to $20.80 after the company reported better-than-expected Q1 results. QuinStreet, Inc. (NASDAQ: QNST ) rose 16% to $16.93 following strong quarterly sales. Unity Software Inc. (NYSE: U ) climbed 15.8% to $42.10. Unity Software''s mobile game publishing solution Supersonic deepened … Full story available on Benzinga.
Abbott Laboratories (NYSE: ABT ) agrees to acquire Cardiovascular Systems Inc (NASDAQ: CSII ) for $20/share for an equity value of approximately $890 million . CSI offers devices for atherectomy, a minimally invasive treatment for plaque build-up in arteries that can restrict blood flow. Procedural use of atherectomy can help maximize the benefits of standard balloon angioplasty or stent treatments … Full story available on Benzinga.com
Cardiovascular Systems Misses Q2 EPS by 5c
Cardiovascular Systems press release (CSII): Q2 GAAP EPS of -$0.20 misses by $0.05.Revenue of $61.5M (+4.1% Y/Y) misses by $3.1M.The Adjusted EBITDA loss increased to $3.7M from…
Leading healthcare company Abbott (NYSE:ABT) announced the acquisition of Cardiovascular Systems (NASDAQ:CSII), a medical device maker for peripher…
Cardiovascular Systems (CSII) is scheduled to announce Q2 earnings results on Thursday, February 9th, before market open.The consensus EPS Estimate is -$0.15 (+34.8% Y/Y) and the…
Cardiovascular Systems (NASDAQ: CSII ) is set to give its latest quarterly earnings report on Thursday, 2023-02-09. Here''s what investors need to know before the announcement. Analysts estimate that Cardiovascular Systems will report an earnings per share (EPS) of $-0.15. Cardiovascular Systems bulls will hope to hear the company announce they''ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the … Full story available on Benzinga.com